Literature DB >> 27540058

Complete Genome Sequences of Three Historically Important, Spatiotemporally Distinct, and Genetically Divergent Strains of Zika Virus: MR-766, P6-740, and PRVABC-59.

Sang-Im Yun1, Byung-Hak Song1, Jordan C Frank1, Justin G Julander1, Irina A Polejaeva1, Christopher J Davies1, Kenneth L White1, Young-Min Lee2.   

Abstract

Here, we report the 10,807-nucleotide-long consensus RNA genome sequences of three spatiotemporally distinct and genetically divergent Zika virus strains, with the functionality of their genomic sequences substantiated by reverse genetics: MR-766 (African lineage, Uganda, 1947), P6-740 (Asian lineage, Malaysia, 1966), and PRVABC-59 (Asian lineage-derived American strain, Puerto Rico, 2015).
Copyright © 2016 Yun et al.

Entities:  

Year:  2016        PMID: 27540058      PMCID: PMC4991703          DOI: 10.1128/genomeA.00800-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Zika virus (ZIKV) is a positive-stranded RNA virus of the family Flaviviridae, genus Flavivirus (1). ZIKV is spread among humans primarily through the bite of infected Aedes species mosquitoes (2), but it can also be transmitted from an infected mother to her child during pregnancy (3–7) or by sexual contact (8, 9) or blood transfusion (10). In nature, ZIKV is probably maintained in a sylvatic cycle involving wild primates and arboreal mosquitoes (11–16). Although ZIKV infection generally causes a mild and self-limiting illness in infected individuals (17, 18), it has recently been associated with a growing number of severe neurological disorders, including Guillain-Barré syndrome in adults and microcephaly in newborns (3–5, 19–21). Historically, ZIKV spread from equatorial Africa and Asia (22–33) to the Pacific Islands (34–40), and most recently, to Latin America (41–46); it is now a pandemic in progress (47–50). Over the past half century, a significant number of ZIKV isolates have been obtained sporadically from three continents (Africa, Asia, and America); however, little is known about the genetic variation among these geographically and temporally distinct ZIKVs because of the limited number of fully sequenced ZIKV genomes (27, 51–61). Here, we have determined the complete genome sequences of three historically important spatiotemporally distinct ZIKVs (Table 1): (i) MR-766, the first ZIKV isolated in Uganda from a sentinel rhesus monkey in 1947 (33); (ii) P6-740, the first non-African strain isolated in Malaysia from a pool of Aedes aegypti mosquitoes in 1966 (23); and (iii) PRVABC-59, the current American epidemic strain isolated in Puerto Rico from a human patient in 2015 (62). The consensus nucleotide sequence for each of the three genomic RNAs was determined by direct sequencing of three overlapping cDNA amplicons (nucleotides [nt] 1 to 4530, nt 2339 to 7386, and nt 5626 to 10611 [numbered based on LC002520]) that cover the entire viral genome except the 5′ and 3′ termini; 5′- and 3′-rapid amplification of cDNA ends was then performed to obtain the missing terminal sequences (nt 1 to 163 and nt 10053 to 10807), according to our established protocols (63, 64).
TABLE 1

Summary of the complete genome sequences of three spatiotemporally distinct genetically divergent ZIKVs with the accession numbers deposited at the GenBank sequence database

StrainCountry of isolationCollection dateHostComplete genome size (nt)5′ NCRa (nt)ORFb (nt)3′ NCR (nt)Genetic lineageGenBank accession no.
MR-766cUgandaApril 1947Monkey (Macaca mulatta)10,80710610,272429AfricanKX377335
P6-740dMalaysiaJuly 1966Mosquito (Aedes aegypti)10,80710710,272428AsianKX377336
PRVABC-59ePuerto RicoDecember 2015Human (Homo sapiens)10,80710710,272428AsianKX377337

NCR, noncoding region.

ORF, open reading frame.

The genome of MR-766 has been fully sequenced in this study and by three other independent groups (accession numbers AY632535, LC002520, and KU955594), and their nucleotide sequences are not identical, most likely because of variations in the cultivation history of the virus.

The partial coding sequence of P6-740 has been sequenced previously (accession no. HQ234499).

The genome of PRVABC-59 has been sequenced previously by two research groups (accession numbers KU501215 and KX087101), but both lack the 5′- and 3′-terminal sequences.

Summary of the complete genome sequences of three spatiotemporally distinct genetically divergent ZIKVs with the accession numbers deposited at the GenBank sequence database NCR, noncoding region. ORF, open reading frame. The genome of MR-766 has been fully sequenced in this study and by three other independent groups (accession numbers AY632535, LC002520, and KU955594), and their nucleotide sequences are not identical, most likely because of variations in the cultivation history of the virus. The partial coding sequence of P6-740 has been sequenced previously (accession no. HQ234499). The genome of PRVABC-59 has been sequenced previously by two research groups (accession numbers KU501215 and KX087101), but both lack the 5′- and 3′-terminal sequences. In all three ZIKV strains, the genomic RNA is 10,807 nt in length, with a single 10,272-nt open reading frame (ORF) flanked by a 106- or 107-nt 5′ noncoding region (NCR) and a 428- or 429-nt 3′ NCR (Table 1). The ORF encodes a 3,423-amino acid (aa) polyprotein predicted to be cleaved into 10 proteins: 122-aa C, 168-aa prM, 504-aa E, 352-aa NS1, 226-aa NS2A, 130-aa NS2B, 617-aa NS3, 150-aa NS4A, 251-aa NS4B, and 903-aa NS5. The functionality of all three genomic sequences was validated by generating their full-length infectious cDNA clones (our unpublished data). A phylogenetic analysis using the nucleotide sequences of the 29 available ZIKV genomes (15 complete and 14 near-complete) revealed two major genetic lineages: African, including MR-766; and Asian, including both P6-740 and PRVABC-59, with PRVABC-59 derived from an ancestor of the Asian lineage, in agreement with recent reports (6, 7, 38, 43, 62, 65, 66). Our findings provide a foundation for comparative functional genomics studies of ZIKV biology.

Accession number(s).

The accession numbers deposited at the GenBank sequence database are listed in Table 1.
  60 in total

1.  Zika virus. I. Isolations and serological specificity.

Authors:  G W A DICK; S F KITCHEN; A J HADDOW
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

Review 2.  Zika virus: a previously slow pandemic spreads rapidly through the Americas.

Authors:  Derek Gatherer; Alain Kohl
Journal:  J Gen Virol       Date:  2015-12-18       Impact factor: 3.891

3.  Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses.

Authors:  G Kuno; G-J J Chang
Journal:  Arch Virol       Date:  2007-01-03       Impact factor: 2.574

4.  Molecular characterization of three Zika flaviviruses obtained from sylvatic mosquitoes in the Central African Republic.

Authors:  Nicolas Berthet; Emmanuel Nakouné; Basile Kamgang; Benjamin Selekon; Stéphane Descorps-Declère; Antoine Gessain; Jean-Claude Manuguerra; Mirdad Kazanji
Journal:  Vector Borne Zoonotic Dis       Date:  2014-12       Impact factor: 2.133

5.  Development and application of a reverse genetics system for Japanese encephalitis virus.

Authors:  Sang-Im Yun; Seok-Yong Kim; Charles M Rice; Young-Min Lee
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

6.  Zika virus emergence in mosquitoes in southeastern Senegal, 2011.

Authors:  Diawo Diallo; Amadou A Sall; Cheikh T Diagne; Oumar Faye; Ousmane Faye; Yamar Ba; Kathryn A Hanley; Michaela Buenemann; Scott C Weaver; Mawlouth Diallo
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

7.  Zika virus, French polynesia, South pacific, 2013.

Authors:  Van-Mai Cao-Lormeau; Claudine Roche; Anita Teissier; Emilie Robin; Anne-Laure Berry; Henri-Pierre Mallet; Amadou Alpha Sall; Didier Musso
Journal:  Emerg Infect Dis       Date:  2014-06       Impact factor: 6.883

8.  Complete Genome Sequences of Zika Virus Strains Isolated from the Blood of Patients in Thailand in 2014 and the Philippines in 2012.

Authors:  D W Ellison; J T Ladner; R Buathong; M T Alera; M R Wiley; L Hermann; W Rutvisuttinunt; C Klungthong; P Chinnawirotpisan; W Manasatienkij; M C Melendrez; I Maljkovic Berry; B Thaisomboonsuk; P Ong-Ajchaowlerd; W Kaneechit; J M Velasco; I A Tac-An; D Villa; C B Lago; V G Roque; T Plipat; A Nisalak; A Srikiatkhachorn; S Fernandez; I K Yoon; A D Haddow; G F Palacios; R G Jarman; L R Macareo
Journal:  Genome Announc       Date:  2016-05-12

9.  Zika virus in Gabon (Central Africa)--2007: a new threat from Aedes albopictus?

Authors:  Gilda Grard; Mélanie Caron; Illich Manfred Mombo; Dieudonné Nkoghe; Statiana Mboui Ondo; Davy Jiolle; Didier Fontenille; Christophe Paupy; Eric Maurice Leroy
Journal:  PLoS Negl Trop Dis       Date:  2014-02-06

10.  Imported zika virus infection from the cook islands into australia, 2014.

Authors:  Alyssa T Pyke; Michelle T Daly; Jane N Cameron; Peter R Moore; Carmel T Taylor; Glen R Hewitson; Jan L Humphreys; Richard Gair
Journal:  PLoS Curr       Date:  2014-06-02
View more
  21 in total

Review 1.  Therapeutic Approaches for Zika Virus Infection of the Nervous System.

Authors:  Rachel P M Abrams; Jamie Solis; Avindra Nath
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis.

Authors:  Derek L Carbaugh; Ralph S Baric; Helen M Lazear
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

Review 3.  Flavivirus Envelope Protein Glycosylation: Impacts on Viral Infection and Pathogenesis.

Authors:  Derek L Carbaugh; Helen M Lazear
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

Review 4.  Zika virus: An emerging flavivirus.

Authors:  Sang-Im Yun; Young-Min Lee
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

5.  Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein.

Authors:  Vidyanath Chaudhary; Kit-San Yuen; Jasper Fuk-Woo Chan; Ching-Ping Chan; Pei-Hui Wang; Jian-Piao Cai; Shuo Zhang; Mifang Liang; Kin-Hang Kok; Chi-Ping Chan; Kwok-Yung Yuen; Dong-Yan Jin
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

6.  Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.

Authors:  Shenyou Nie; Yuan Yao; Fangrui Wu; Xiaowei Wu; Jidong Zhao; Yuanda Hua; Jingyu Wu; Tong Huo; Yi-Lun Lin; Alexander R Kneubehl; Megan B Vogt; Josephine Ferreon; Rebecca Rico-Hesse; Yongcheng Song
Journal:  J Med Chem       Date:  2021-02-17       Impact factor: 7.446

Review 7.  An Update on Zika Virus in Asia.

Authors:  Sl Ki Lim; Jacqueline Kyungah Lim; In Kyu Yoon
Journal:  Infect Chemother       Date:  2017-06

8.  Zika genomics urgently need standardized and curated reference sequences.

Authors:  Kristof Theys; Pieter Libin; Kai Dallmeier; Andrea-Clemencia Pineda-Peña; Anne-Mieke Vandamme; Lize Cuypers; Ana B Abecasis
Journal:  PLoS Pathog       Date:  2017-09-07       Impact factor: 6.823

9.  Lineage-dependent differences in the disease progression of Zika virus infection in type-I interferon receptor knockout (A129) mice.

Authors:  Stuart D Dowall; Victoria A Graham; Emma Rayner; Laura Hunter; Barry Atkinson; Geoff Pearson; Mike Dennis; Roger Hewson
Journal:  PLoS Negl Trop Dis       Date:  2017-07-03

Review 10.  Autoimmune Neurological Conditions Associated With Zika Virus Infection.

Authors:  Yeny Acosta-Ampudia; Diana M Monsalve; Luis F Castillo-Medina; Yhojan Rodríguez; Yovana Pacheco; Susan Halstead; Hugh J Willison; Juan-Manuel Anaya; Carolina Ramírez-Santana
Journal:  Front Mol Neurosci       Date:  2018-04-11       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.